Clinical Trials Logo

Seach Results for — “aids”

Testing Decision Aids About Early Stage Prostate Cancer

Promoting Shared Decision Making in Prostate Cancer Through Decision Aids

This is an educational intervention study testing the effects of decision aids in promoting patient participation in early stage prostate cancer treatment decision making. The purpose of this study is to compare patient-physician communication between patients who receive a DVD that models patient communication strategies vs. those who do not receive a DVD. All patients will also receive a written decision aid that describes treatment options for early stage prostate cancer. The Investigators hypothesize that the DVD will: - increase patients' perceptions of the importance of their preferences to their decision making - increase patients' perceptions of their intention to discuss their values and preferences with their urologists and radiation oncologists - increase patients' actual engagement with their physician during the clinical encounter - increase the concordance between patient decision making preferences and actual decision making outcomes - increase long term satisfaction with decision on type of treatment selected - increase patient satisfaction with their decision and the decision making process - influence patient perception of his physician (e.g., trust) and of the diagnosis visit

NCT02053389 — Prostatic Neoplasms
Status: Completed
http://inclinicaltrials.com/prostatic-neoplasms/NCT02053389/

AIDS 347: IL-6 Blockade in Treated HIV Infection - IL-6

AIDS 347: IL-6 Blockade in Treated HIV Infection

The study is a phase I/II, double-blind, placebo-controlled, randomized cross-over clinical trial of tocilizumab (TCZ) or placebo in HIV-infected subjects receiving antiretroviral therapy with suppressed viral replication and CD4+ T cell count ≥350 and ≤1,000 cells/mm3)

NCT02049437 — HIV Infections
Status: Completed
http://inclinicaltrials.com/hiv-infections/NCT02049437/

An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy)

An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS

The goal of this research study is to compare 2 different phone-based programs for quitting smoking for people with HIV/AIDS.

NCT02029612 — Tobacco Use Cessation
Status: Withdrawn
http://inclinicaltrials.com/tobacco-use-cessation/NCT02029612/

A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)

A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)

The purpose of this study is to test the acceptability and feasibility of a "toolkit" of patient decision aids (PtDAs) for heart failure patients who are considering an ICD implant.

NCT02026102 — Sudden Cardiac Death
Status: Completed
http://inclinicaltrials.com/sudden-cardiac-death/NCT02026102/

Smoking Cessation for People Living With HIV/AIDS

Behavioral Smoking Cessation Treatment for People Living With HIV/AIDS

In this proposed study with People Living with HIV/AIDS (PLWHA), we will use a stepped care model called a Sequential Multiple Assignment Randomized Trial (SMART) to examine the efficacy of low- and high-intensity smoking cessation treatments for nicotine dependent PLWHA that incorporate the current standard of care and prize-based contingency management. Intervention will be administered in a community-based HIV integrated care clinic in downtown Detroit, which has the highest prevalence rates of HIV/AIDS and smoking in Michigan. Phase 1 will last 4 weeks, and will involve brief intervention to help participants stop smoking. For phase 2, participants will be assigned to different study arms depending on whether they are Responders (reduced their smoking) or Non-responders (continued to smoke). 1. Phase 1: We hypothesize that brief high-magnitude prize contingency management will result in greater reduction in smoking than standard of care alone. 2. Phase 2a: We hypothesize that non-responders who are assigned to contingency management will be more likely to reduce their smoking throughout treatment and to abstain from smoking at all follow-up points. 3. Phase 2b: We hypothesize that responders who are assigned to monitoring and low-magnitude prize contingency management will be more likely to maintain their reduced or abstinent smoking status at all follow-up time-points.

NCT01965405 — HIV
Status: Active, not recruiting
http://inclinicaltrials.com/hiv/NCT01965405/

Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials

Improving Participation in AMC Clinical Trials (IMPACTS)

This pilot research trial studies factors affecting patient participation in Acquired Immune Deficiency Syndrome (AIDS) Malignancy Clinical Trials Consortium clinical trials. Determining how patients makes decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are satisfied with their decision to participate.

NCT01946217 — HIV Infection
Status: Completed
http://inclinicaltrials.com/hiv-infection/NCT01946217/

Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E

Randomized, Double Blind Evaluation of Different One-Year Boosts After Sanofi Pasteur Live Recombinant ALVAC-HIV (vCP1521) and Global Solutions for Infectious Diseases (GSID) gp120 B/E (AIDSVAX® B/E) Prime-Boost Regimen in HIV-uninfected Thai Adults

The primary purpose of the study is to better define the relative contributions of AIDSVAX® B/E alone, ALVAC-HIV alone, or ALVAC-HIV plus AIDSVAX® B/E combination to the observed immune profile in the weeks and months after receiving the original prime and boost vaccine regimen from study protocol RV 144, and their booster effects in both the systemic and mucosal compartments. In addition, this study will provide more intensive and comprehensive characterization of the innate, cell-mediated and humoral immune responses than possible within the RV 144 study.

NCT01931358 — HIV Infections
Status: Active, not recruiting
http://inclinicaltrials.com/hiv-infections/NCT01931358/

Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth

Adapting and Evaluating an Evidence-Based Intervention to Prevent HIV/AIDS Risk Among Apache Youth

The investigators seek to adapt, implement and evaluate a randomized controlled trial of an evidence based intervention delivered by Apache interventionists to reduce HIV/AIDS risk, targeting Apache adolescents. Specific study objectives include: 1. To perform formative research through focus groups and individual interviews on attitudes, practices and intervention preferences among Apache adolescents and community stakeholders. 2. To adapt the Focus on Youth (FOY) evidence-based intervention using findings from the formative research, components of Protection Motivation Theory, and input from a community advisory board. 3. To enroll 304 White Mountain Apache youth ages 13-19 to participate in a randomized intervention trial measuring behavior change at 6- and 12- months follow-up. 4. To determine the feasibility of gathering biological specimens via self-administered swabs to track sexually transmitted diseases among 18-19 year olds enrolled in this and future studies.

NCT01910714 — HIV/AIDS
Status: Completed
http://inclinicaltrials.com/hiv-aids/NCT01910714/

Effectiveness of P02 Digital Hearing Aids - P02

Effectiveness of NECTEC Model, Body-worn, Digital Hearing Aids and Cost of Screening and Hearing Aids Service in Elders

To test the effectiveness of body-worn, digital hearing aids, model 02 which is developed by the National Electronics and Computer Technology Center, Thailand.

NCT01902914 — Sensorineural Hearing Loss
Status: Unknown status
http://inclinicaltrials.com/sensorineural-hearing-loss/NCT01902914/

Central Auditory Processing and the Use of Hearing Aids - CAPHA

Evaluation of the Central Auditory Processing in Patients (Elder Than 45 Years Old) With Bilateral Sensorineural Hearing Loss and the Change of the Central Auditory Processing Ability by the Use of Hearing Aids (CAPHA)

The purpose of this study is to evaluate the central auditory processing in patients with bilateral sensorineural hearing loss and to observe the change of the central auditory processing ability after using hearing aids.

NCT01897181 — Auditory Processing Disorder, Central
Status: Completed
http://inclinicaltrials.com/auditory-processing-disorder-central/NCT01897181/